CVS Health is reportedly closing down a number of its pharmacies installed in Target stores in the United States. The pharmacies are expected to be removed from the discount department store chain’s locations in early 2024.
As per CNN Business, the spokesperson of CVS Health confirmed the closure of its drug stores on Thursday, Jan. 11. It was said that the decision to stop its operations inside the Target outlets comes as retail pharmacy companies in the U.S. are faced with growing difficulties with their workforce, prescriptions business, and other aspects.
Schedule of the Pharmacy Shut Downs
The American retail pharmacy brand said it will close its stores in Target locations from next month until April this year. The company also said this is part of its strategy to spread out its stores and pharmacies even more. This information was shared with CNN through an email from CVS Pharmacy’s spokesperson, Amy Thibault.
The closing of the pharmacies is “based on our evaluation of changes in population, consumer buying patterns and future health needs to ensure we have the right pharmacy format in the right locations for patients,” the spokeswoman said.
Select Locations are Affected
Forbes reported that only select locations of Target stores are losing their CVS Health outlets this year. Then again, the company did not mention specific locations for the shutdown. The company is currently operating around 9,000 stores across the country.
“The pharmacy closures will begin in February and be completed by the end of April and impacted employees will be offered comparable roles within the company,” CVS Health said in a statement. “The closures are part of our plan to realign our national retail footprint and reduce store and pharmacy density and are based on our evaluation of changes in population, consumer buying patterns and future health needs to ensure we have the right pharmacy format in the right locations for patients.”
Photo by: Marques Thomas/Unsplash


Meta Reportedly Developing ‘Arena’ Prediction Market App to Rival Polymarket and Kalshi
Tesla and NatPower Partner on $5 Billion Battery Storage Expansion in Europe
Alibaba Shares Fall After Anthropic Alleges Massive AI Model Distillation Campaign
Cerebras Revenue Forecast Tops Expectations, but Margin Concerns Weigh on Stock
Bayer Wins Major U.S. Supreme Court Roundup Lawsuit, Shares Surge
Samsung and SK Hynix Shares Jump After Micron Earnings Boost AI Chip Optimism
Pelosi Discloses Major Intel and Uber Call Option Purchases Worth Up to $6 Million
SK Hynix Moves Closer to New York ADR Listing Amid AI Chip Boom
Fortescue Faces Class Action Over Sexual Harassment Claims at Australian Mining Sites
OpenAI IPO Delay Weighs on SoftBank Shares as AI Valuation Concerns Grow
Kioxia Targets U.S. Listing as AI Chip Boom Accelerates
Micron Stock Surges on Strong AI Demand, Record Revenue, and Bullish Q4 Forecast
Samsung, SK Hynix to Unveil Record AI and Semiconductor Investment Plans Worth Over $646 Billion
Trump Orders DOJ Investigation Into Exxon, Chevron Over High Gas Prices
Heineken Names JDE Peet’s CEO Rafael Oliveira as New Chief Executive
Johns Hopkins University Lays Off 110 Employees as Federal Research Funding Declines
Ryan Cohen Rejects GameStop Pay Package, Prepares New eBay Acquisition Plan 



